# Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity

> **NCT00221442** · PHASE3 · COMPLETED · sponsor: **Lindner Center of HOPE** · enrollment: 60 (actual)

## Conditions studied

- Binge Eating Disorder Associated With Obesity

## Interventions

- **DRUG:** Zonegran
- **DRUG:** sugar pill

## Key facts

- **NCT ID:** NCT00221442
- **Lead sponsor:** Lindner Center of HOPE
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-08
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2011-06-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00221442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00221442, "Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00221442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*